InfectionCSPC Zhongqi Pharmaceutical Technology identifies new antivirals for RSVCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co. Ltd. has patented compounds reported to be useful for the treatment of respiratory syncytial virus (RSV) infection.